BRD2 and endothelial dysfunction: The association between ADT and an increased risk of developing cardiometabolic complications involves multiple factors, which include a decrease in the testosterone level, an elevation in follicle-stimulating hormone (FSH), changes in body composition, increased insulin resistance, and endothelial dysfunction (77).